ITGR LOGO (2019-09-25) intgr_ful_r_4cp_hor.png
Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies
January 10, 2024 16:15 ET | Integer Holdings Corporation
~ Preliminary unaudited full year 2023 sales increase 16% versus 2022 ~~ Acquisition adds highly differentiated micro machining capability in high growth end markets ~~ Schedules conference call for...
ITGR LOGO (2019-09-25) intgr_ful_r_4cp_hor.png
Integer to Participate in 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024 08:00 ET | Integer Holdings Corporation
PLANO, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference to be held in San...
Esperion Logo (primary).png
Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update
January 11, 2022 08:00 ET | Esperion Therapeutics, Inc.
– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S....
Caribou Logo.png
Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 16:05 ET | Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Esperion Logo (primary).png
Esperion to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 21, 2020 08:00 ET | Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Tim M. Mayleben, will present at the virtual 39th Annual J.P....
logo color s and clearside.jpg
Clearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 06, 2020 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Esperion Logo (primary).png
Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference
January 03, 2018 16:30 ET | Esperion Therapeutics, Inc.
Fireside Chat Webcast on Wednesday, January 10, 2018 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time ANN ARBOR, Mich., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc....